SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-13-302836
Filing Date
2013-07-25
Accepted
2013-07-25 16:58:04
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B4 d528948d424b4.htm 424B4 1714143
2 GRAPHIC g528948g04o88_k.jpg GRAPHIC 30364
3 GRAPHIC g528948g11j10_k.jpg GRAPHIC 60135
4 GRAPHIC g528948g19p27_k.jpg GRAPHIC 25151
5 GRAPHIC g528948g21l00_k.jpg GRAPHIC 53229
6 GRAPHIC g528948g30a20.jpg GRAPHIC 70539
7 GRAPHIC g528948g36j61.jpg GRAPHIC 38352
8 GRAPHIC g528948g38i82.jpg GRAPHIC 22361
9 GRAPHIC g528948g45u29_k.jpg GRAPHIC 31209
10 GRAPHIC g528948g60d18_k.jpg GRAPHIC 54648
11 GRAPHIC g528948g64k23.jpg GRAPHIC 49701
12 GRAPHIC g528948g75f20.jpg GRAPHIC 45249
13 GRAPHIC g528948g75q69.jpg GRAPHIC 46183
  Complete submission text file 0001193125-13-302836.txt   2443204
Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-189305 | Film No.: 13987006
SIC: 2834 Pharmaceutical Preparations